Page 2178 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 2178

Chapter 129  Laboratory Evaluation of Hemostatic and Thrombotic Disorders  1931


            19.  Pai  M,  Wang  G,  Moffat  KA,  et al:  Diagnostic  usefulness  of  a    25.  Perry  DJ,  Fitzmaurice  DA,  Kitchen  S,  et al:  Point-of-care  testing  in
               lumi-aggregometer  adenosine  triphosphate  release  assay  for  the  assess-  haemostasis. Br J Haematol 150:501–514, 2010.
               ment  of  platelet  function  disorders.  Am  J  Clin  Pathol  136:350–358,   26.  Mauch  J,  Spielmann  N,  Hartnack  S,  et al:  Intrarater  and  interrater
               2011.                                                 variability of point of care coagulation testing using the ROTEM delta.
            20.  Ng C, Motto DG, Di Paola J: Diagnostic approach to von Willebrand   Blood Coagul Fibrinolysis 22:662–666, 2011.
               disease. Blood 125:2029–2037, 2015.                27.  Kitchen  DP,  Jennings  I,  Kitchen  S,  et al:  Bridging  the  gap  between
            21.  Sadler  JE:  Von  Willebrand  disease  type  1:  a  diagnosis  in  search  of  a   point-of-care testing and laboratory testing in hemostasis. Semin Thromb
               disease. Blood 101:2089–2093, 2003.                   Hemost 2015.
            22.  Muszbek  L,  Bagoly  Z,  Cairo  A,  et al:  Novel  aspects  of  factor  XIII   28.  Middeldorp S, van Hylckama Vlieg A: Does thrombophilia testing help
               deficiency. Curr Opin Hematol 18:366–372, 2011.       in  the  clinical  management  of  patients?  Br  J  Haematol  143:321–335,
            23.  Young G, Sorensen B, Dargaud Y, et al: Thrombin generation and whole   2008.
               blood viscoelastic assays in the management of hemophilia: current state   29.  Cuker A, Siegal DM, Crowther MA, et al: Laboratory measurement of
               of art and future perspectives. Blood 121:1944–1950, 2013.  the anticoagulant activity of the non-vitamin K oral anticoagulants. J Am
            24.  Afshari  A,  Wikkelso  A,  Brok  J,  et al: Thrombelastography  (TEG)  or   Coll Cardiol 64:1128–1139, 2014.
               thromboelastometry (ROTEM) to monitor haemotherapy versus usual   30.  Samama MM, Martinoli JL, LeFlem L, et al: Assessment of laboratory
               care  in  patients  with  massive  transfusion.  Cochrane  Database  Syst  Rev   assays to measure rivaroxaban–an oral, direct factor Xa inhibitor. Thromb
               CD007871, 2011.                                       Haemost 103:815–825, 2010.
   2173   2174   2175   2176   2177   2178   2179   2180   2181   2182   2183